Host RNA Expression Profiles and Protein Biomarkers in Neonatal Herpes Simplex Virus Infection

NCT05226949 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 159

Last updated 2022-12-28

No results posted yet for this study

Summary

This study seeks to identify and test host RNA expression profiles in context to protein biomarkers in dried blood spot samples as novel diagnostic markers of neonatal herpes simplex virus infection and to improve the understanding of the pathogenesis of the disease.

Conditions

  • Neonatal Herpes Simplex Infection
  • Neonatal HSV Infection
  • Neonatal Infection
  • Newborn; Infection
  • Herpes Simplex Virus Infection
  • Neonatal Sepsis
  • Neonatal Death
  • Viral Infection

Sponsors & Collaborators

  • Statens Serum Institut

    collaborator OTHER
  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Kia Hee Schultz Dungu, MD · Rigshospitalet, Denmark

  • Ulrikka Nygaard, Ass Prof PhD · Rigshospitalet, Denmark

Eligibility

Min Age
0 Days
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-02-28
Completion
2022-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05226949 on ClinicalTrials.gov